Presence of intrauterine adhesions at second‐look hysteroscopy (6‐12 weeks) · women treated by operative hysteroscopy for uterine pathology
Any anti‐adhesion therapy A may leads to lower presence of intrauterine adhesions at second‐look hysteroscopy (6‐12… compared with anti‐adhesion therapy B following operative hysteroscopy (low certainty).
1 finding from 1 review
Presence of intrauterine adhesions at second‐look hysteroscopy (6‐12 weeks) · women treated by operative hysteroscopy for uterine pathology associated with subfertility or adverse pregnancy outcome
Any anti‐adhesion therapy may leads to lower presence of intrauterine adhesions at second‐look hysteroscopy… compared with placebo or no treatment following operative hysteroscopy (low certainty).
1 finding from 1 review
Moderate or severe OHSS · women at high risk of OHSS
It is very uncertain whether HES changes moderate or severe OHSS compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Live birth · women at high risk of OHSS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pregnancy rate · women at high risk of OHSS
It is very uncertain whether HES changes pregnancy rate compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Adverse effects · women at high risk of OHSS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Live birth · women treated by operative hysteroscopy for uterine pathology
Any anti‐adhesion therapy A showed no clear difference in live birth a compared with anti‐adhesion therapy B following operative hysteroscopy (low certainty).
1 finding from 1 review
Adhesion score · patients with adhesion prevention after gynaecological surgery
1 finding from 1 review
Incidence of adhesions ‐ de novo Incidence at second‐look laparoscopy · patients with adhesion prevention after gynaecological surgery
Analysis 7 ‐ Collagen membrane with polyethylene glycol and glycerol may leads to lower incidence of adhesions ‐ de novo Incidence at second‐look laparoscopy compared with ringer's lactate (low certainty).
1 finding from 1 review
Incidence of adhesions ‐ re‐formation (or mixture) Incidence at second‐look laparoscopy · patients with adhesion prevention after gynaecological surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in frequency of hot flushes from baseline to end of study · women with menopausal hot flushes
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
Transdermal beta‐estradiol patch showed no clear difference in frequency of hot flushes Beta‐estradiol patch 0.0375‐0.10 mg/day compared with placebo (low certainty).
1 finding from 1 review
Change in frequency of hot flushes from baseline to end of study · women with hot flushes
Intranasal beta‐estradiol showed no clear difference in frequency of hot flushes Change from baseline Intranasal… compared with placebo (moderate certainty).
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
1 finding from 1 review
Frequency of hot flushes Oral beta‐estradiol 1.0 and 2.0 mg/day vs CEE 0.625 or 1.25 mg/day · women with hot flushes
1 finding from 1 review
Intensity of hot flushes Beta‐estradiol patch 0.025‐0.05 mg/day · women with hot flushes
Transdermal beta‐estradiol patch showed no clear difference in intensity of hot flushes Beta‐estradiol patch 0.025‐0.05 mg/day compared with placebo (low certainty).
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
1 finding from 1 review
Hot flush frequency (number/day) · women with hot flushes
Oral beta‐estradiol showed no clear difference in frequency of hot flushes Oral beta‐estradiol 0.5‐1.0 mg/day compared with placebo (low certainty).
1 finding from 1 review
Live birth · women treated by operative hysteroscopy for uterine pathology associated with subfertility or adverse pregnancy outcome
It is very uncertain whether any anti‐adhesion therapy changes live birth a compared with placebo or no treatment following operative hysteroscopy (very low certainty).
1 finding from 1 review
Incidence of adhesions ‐ de novo Incidence at second‐look laparoscopy · women having gynaecological surgery
It is very uncertain whether analysis 2 ‐ Oxidised regenerated cellulose changes incidence of adhesions ‐ de novo Incidence at second‐look laparoscopy compared with no treatment at laparotomy (very low certainty).
1 finding from 1 review